Becton, Dickinson and Company (bdx)
BDX Earnings
Public earnings and growth snapshot for Becton, Dickinson and Company. Full earnings calendars, surprises, and multi-year history are available in Vest Terminal.
| Earnings growth (YoY) | -31.4% |
| Revenue growth (YoY) | 5.4% |
| Trailing P/E | 31.63 |
| Forward P/E | 13.73 |
| Last price | $182.52 |
| Market cap | $49.72B |
Start Free — open BDX in Vest Terminal
Access live data, filings, ownership, and analysis for Becton, Dickinson and Company.
Becton, Dickinson and Company FAQ
What does Becton, Dickinson and Company (BDX) do?
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worl…
What is BDX's P/E ratio?
Becton, Dickinson and Company has a trailing P/E of 31.63× based on publicly available market data.
Does BDX pay a dividend?
Indicated dividend yield: 2.3%. Confirm ex-dates and payout history in Vest Terminal.
What sector is BDX in?
Becton, Dickinson and Company is classified in Healthcare (Medical Instruments & Supplies) on NYQ.
What is BDX's market capitalization?
Approximate market cap: $49.72B.
What are the main risks for BDX?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of BDX?
Potential positives include revenue growth of 5.4% year-over-year, gross margin of 46.9% supports competitive unit economics.
Where can I get analyst estimates for BDX?
Public analyst price targets and consensus for Becton, Dickinson and Company are on the free /stocks/bdx/estimates page. Deeper estimate history and models are available in Vest Terminal.